SERPINA1 and metabolic dysfunction-associated steatohepatitis: Furthermore, it was beneficial for the diagnosis of NASH by combining AAT-A3F with fibrosis markers such as M2BPGi and FIB4 index depending of progression stage of NASH (Fig. 5).